Kesharwani P - Search Results

1

Nanotechnology-based approaches applied to nutraceuticals.

Singh AR, Desu PK, Nakkala RK, Kondi V, Devi S, Alam MS, Hamid H, Athawale RB, Kesharwani P. Singh AR, et al. Among authors: kesharwani p. Drug Deliv Transl Res. 2022 Mar;12(3):485-499. doi: 10.1007/s13346-021-00960-3. Epub 2021 Mar 18. Drug Deliv Transl Res. 2022. PMID: 33738677 Review.

2

Nanotechnology based approaches for anti-diabetic drugs delivery.

Kesharwani P, Gorain B, Low SY, Tan SA, Ling ECS, Lim YK, Chin CM, Lee PY, Lee CM, Ooi CH, Choudhury H, Pandey M. Kesharwani P, et al. Diabetes Res Clin Pract. 2018 Feb;136:52-77. doi: 10.1016/j.diabres.2017.11.018. Epub 2017 Nov 28. Diabetes Res Clin Pract. 2018. PMID: 29196152 Review.

3

Formulation and evaluation of gastro-retentive floating bilayer tablet for the treatment of hypertension.

Maddiboyina B, Hanumanaik M, Nakkala RK, Jhawat V, Rawat P, Alam A, Foudah AI, Alrobaian MM, Shukla R, Singh S, Kesharwani P. Maddiboyina B, et al. Among authors: kesharwani p. Heliyon. 2020 Nov 13;6(11):e05459. doi: 10.1016/j.heliyon.2020.e05459. eCollection 2020 Nov. Heliyon. 2020. PMID: 33241144 Free PMC article.

4

Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy.

Bhagwat GS, Athawale RB, Gude RP, Md S, Alhakamy NA, Fahmy UA, Kesharwani P. Bhagwat GS, et al. Among authors: kesharwani p. Front Pharmacol. 2020 Nov 27;11:614290. doi: 10.3389/fphar.2020.614290. eCollection 2020. Front Pharmacol. 2020. PMID: 33329007 Free PMC article.

5

Fighting Strategies Against the Novel Coronavirus Pandemic: Impact on Global Economy.

Gorain B, Choudhury H, Molugulu N, Athawale RB, Kesharwani P. Gorain B, et al. Among authors: kesharwani p. Front Public Health. 2020 Dec 9;8:606129. doi: 10.3389/fpubh.2020.606129. eCollection 2020. Front Public Health. 2020. PMID: 33363098 Free PMC article. Review.

6

Recent advances in nanocarriers for nutrient delivery.

Gorantla S, Wadhwa G, Jain S, Sankar S, Nuwal K, Mahmood A, Dubey SK, Taliyan R, Kesharwani P, Singhvi G. Gorantla S, et al. Among authors: kesharwani p. Drug Deliv Transl Res. 2022 Oct;12(10):2359-2384. doi: 10.1007/s13346-021-01097-z. Epub 2021 Nov 29. Drug Deliv Transl Res. 2022. PMID: 34845678 Review.

7

Design, synthesis, in vitro antiproliferative evaluation and GSK-3β kinase inhibition of a new series of pyrimidin-4-one based amide conjugates.

Khan I, Tantray MA, Hamid H, Sarwar Alam M, Sharma K, Kesharwani P. Khan I, et al. Among authors: kesharwani p. Bioorg Chem. 2022 Feb;119:105512. doi: 10.1016/j.bioorg.2021.105512. Epub 2021 Nov 26. Bioorg Chem. 2022. PMID: 34861627

8

Emerging trends of nanotechnology in advanced cosmetics.

Dubey SK, Dey A, Singhvi G, Pandey MM, Singh V, Kesharwani P. Dubey SK, et al. Among authors: kesharwani p. Colloids Surf B Biointerfaces. 2022 Jun;214:112440. doi: 10.1016/j.colsurfb.2022.112440. Epub 2022 Mar 4. Colloids Surf B Biointerfaces. 2022. PMID: 35344873 Review.

9

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy.

Bhagwat GS, Athawale RB, Gude RP, Md S, Alhakamy NA, Fahmy UA, Kesharwani P. Bhagwat GS, et al. Among authors: kesharwani p. Front Pharmacol. 2023 Jan 11;13:1123542. doi: 10.3389/fphar.2022.1123542. eCollection 2022. Front Pharmacol. 2023. PMID: 36712681 Free PMC article.

10

Transdermal delivery of cyclodextrin-solubilized curcumin.

Ghanghoria R, Kesharwani P, Agashe HB, Jain NK. Ghanghoria R, et al. Among authors: kesharwani p. Drug Deliv Transl Res. 2013 Jun;3(3):272-85. doi: 10.1007/s13346-012-0114-y. Drug Deliv Transl Res. 2013. PMID: 25788135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page